This is an old revision of this page, as edited by Yikrazuul (talk | contribs) at 17:00, 3 August 2011 (svg). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 17:00, 3 August 2011 by Yikrazuul (talk | contribs) (svg)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)Names | |
---|---|
IUPAC name (2S)-2-Amino-5-pentanoic acid | |
Other names Targinina; Targininum; Targinine; omega-N-Methylarginine; L-Monomethylarginine; N-Methyl-L-arginine; N-Monomethyl-L-arginine; NG-monomethyl-L-arginine | |
Identifiers | |
CAS Number | |
3D model (JSmol) | |
Abbreviations | L-NMMA |
PubChem CID | |
CompTox Dashboard (EPA) | |
SMILES
| |
Properties | |
Chemical formula | C7H16N4O2 |
Molar mass | 188.23 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). Y verify (what is ?) Infobox references |
N-Methylarginine is an inhibitor of nitric oxide synthase. Chemically, it is a methyl derivative of the amino acid arginine. It is used as a biochemical tool in the study of physiological role of nitric oxide.
See also
References
- Toutouzas, K.; Riga, M.; Stefanadi, E.; Stefanadis, C. (2008). "Asymmetric dimethylarginine (ADMA) and other endogenous nitric oxide synthase (NOS) inhibitors as an important cause of vascular insulin resistance". Hormone and Metabolic Research. 40 (9): 655–659. doi:10.1055/s-0028-1083814. PMID 18792879.
{{cite journal}}
: CS1 maint: multiple names: authors list (link)